NCT01346020
Active, not recruiting
Not Applicable
Genomic Analysis of Patients With Chronic Lymphocytic Leukemia
ConditionsChronic Lymphocytic Leukemia
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Chronic Lymphocytic Leukemia
- Sponsor
- Universitaire Ziekenhuizen KU Leuven
- Enrollment
- 53
- Locations
- 1
- Primary Endpoint
- Time to therapy
- Status
- Active, not recruiting
- Last Updated
- last year
Overview
Brief Summary
This study aims to characterize clonal evolution in chronic lymphocytic leukemia (CLL) using different approaches and to identify a possible association with disease progression, i.e. therapy initiation.
- Samples This monocentric study is carried out using representative bioarchived leukemic samples with a diagnosis of CLL, either at diagnosis or at evolution. These bioarchived samples were collected locally at our center during years of diagnostic activity, and were accurately pathologically, cytogenetically and molecularly characterized.
- Clinical data The clinical data were retrospectively collected through collaboration with the referring physicians.
- Methods Samples will be investigated by means of (1) conventional cytogenetics, (2) fluorescence in situ hybridization (FISH) and (3) SNP-arrays. After analysis of the array data sets, significant results will be validated and in addition, results will be correlated with clinical data.
Investigators
Eligibility Criteria
Inclusion Criteria
- •diagnosis of CLL,
- •at least two available stored samples
Exclusion Criteria
- •at least one inclusion criterium not fulfilled
Outcomes
Primary Outcomes
Time to therapy
Time Frame: baseline to day 1 of therapy
Time from diagnosis to the start of first line therapy
Secondary Outcomes
- Genetic abnormalities detected by karyotyping, FISH or array-analysis(13-102 months)
Study Sites (1)
Loading locations...
Similar Trials
Recruiting
Not Applicable
Understanding Chronic Lymphocytic LeukemiaChronic Lymphocytic LeukemiaNCT04028531Dana-Farber Cancer Institute2,750
Unknown
Not Applicable
Genetic Study of Chronic Lymphocytic Leukemia FamiliesLeukemiaNCT00503256M.D. Anderson Cancer Center4,000
Active, not recruiting
Not Applicable
A Study of Clinical Outcomes in Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in GreeceChronic Lymphocytic LeukemiaNCT04159779AbbVie180
Active, not recruiting
Phase 1
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrationsCTIS2024-514823-41-00Ospedale San Raffaele S.r.l.120
Active, not recruiting
Phase 2
Therapy with ibrutinib for patients with Chronic lymphocytic leukemia with subclonal TP53 aberrations2024-514823-41-00Ospedale San Raffaele S.r.l.120